These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1691405

  • 1. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS, Kupari M.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [Abstract] [Full Text] [Related]

  • 2. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
    Banas JS.
    Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
    [Abstract] [Full Text] [Related]

  • 3. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F, Borghi A, Ruggeri A, Cianfrocca C, Morgagni GL, Bugiardini R.
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [Abstract] [Full Text] [Related]

  • 4. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA.
    J Cardiovasc Pharmacol; 1990 Aug; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [Abstract] [Full Text] [Related]

  • 5. Quinapril in chronic heart failure.
    Northridge DB, Dargie HJ.
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [Abstract] [Full Text] [Related]

  • 6. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL, Sorkin EM.
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V, Mudra H, Bonzel T, Schmidt W, Strand JC, Bakovic-Alt R, Posvar EL.
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ, Posvar E.
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [Abstract] [Full Text] [Related]

  • 9. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW, Baird MG, Tonkon MJ, DiBianco R, Pitt B.
    J Am Coll Cardiol; 1993 Nov 15; 22(6):1557-63. PubMed ID: 8227822
    [Abstract] [Full Text] [Related]

  • 10. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J, Fleck E, Bahrmann H, Delius W, Schultheiss HP, Brunner HR.
    Eur Heart J; 1994 Dec 15; 15 Suppl D():113-22. PubMed ID: 7713100
    [Abstract] [Full Text] [Related]

  • 11. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D, Furgi G, Trojano L, Picone C, Iannuzzi GL, Rossi M, Papa A, Rengo C, Rengo F.
    Am J Ther; 1997 Dec 15; 4(5-6):181-8. PubMed ID: 10423609
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB, Macfadyen RJ, Lees KR, Hillis WS, Reid JL.
    Br J Clin Pharmacol; 1994 Aug 15; 38(2):117-23. PubMed ID: 7981011
    [Abstract] [Full Text] [Related]

  • 13. Overview of quinapril, a new ACE inhibitor.
    Frank GJ, Knapp LE, Olson SC, Phelps MC, Quade MM, Rieger MM, Sedman AJ.
    J Cardiovasc Pharmacol; 1990 Aug 15; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [Abstract] [Full Text] [Related]

  • 14. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP, Elsner D, Riegger GA.
    J Cardiovasc Pharmacol; 1990 Jul 15; 16(1):9-14. PubMed ID: 1696671
    [Abstract] [Full Text] [Related]

  • 15. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D, Frank GJ, Knapp LE, McLain RW.
    Clin Cardiol; 1990 Jun 15; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [Abstract] [Full Text] [Related]

  • 16. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V, Mudra H, Bonzel T, Schmidt W, Schlepper M.
    Z Kardiol; 1996 Nov 15; 85(11):828-38. PubMed ID: 9064945
    [Abstract] [Full Text] [Related]

  • 17. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA.
    Eur Heart J; 1991 Jun 15; 12(6):705-11. PubMed ID: 1830551
    [Abstract] [Full Text] [Related]

  • 18. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
    Holt P, Najm J, Sowton E.
    Eur J Clin Pharmacol; 1986 Jun 15; 31(1):9-14. PubMed ID: 3023100
    [Abstract] [Full Text] [Related]

  • 19. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB, Rose E, Raftery ED, Lahiri A, Elder AT, Shaw TR, Henderson E, Dargie HJ.
    Eur Heart J; 1993 Mar 15; 14(3):403-9. PubMed ID: 8458362
    [Abstract] [Full Text] [Related]

  • 20. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
    Haleen SJ, Weishaar RE, Overhiser RW, Bousley RF, Keiser JA, Rapundalo SR, Taylor DG.
    Circ Res; 1991 May 15; 68(5):1302-12. PubMed ID: 1850330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.